- Report
- February 2025
- 180 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2025
- 187 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 192 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- September 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- August 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 193 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- November 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- May 2024
- 140 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Clinical Trials
- November 2024
- 180 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Clinical Trials
- July 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- April 2024
- 160 Pages
Global
From €4742EUR$4,969USD£3,973GBP
- Report
- February 2021
- 420 Pages
United States
From €2291EUR$2,400USD£1,919GBP
- Report
- November 2023
- 92 Pages
China
From €1718EUR$1,800USD£1,439GBP
- Report
- February 2024
- 142 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- March 2024
- 397 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 145 Pages
Global
From €3006EUR$3,150USD£2,519GBP

Risperidone is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and irritability associated with autism. It is a type of antipsychotic drug that works by changing the activity of certain natural substances in the brain. Risperidone is available in both oral and injectable forms. It is usually taken once or twice daily, depending on the condition being treated. Common side effects include drowsiness, dizziness, and weight gain.
Risperidone is one of the most commonly prescribed antipsychotic medications in the United States. It is used to treat a wide range of mental disorders, including schizophrenia, bipolar disorder, and irritability associated with autism. It is also used to treat symptoms of dementia, such as aggression and agitation.
The market for risperidone is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more